BofA Securities made an adjustment to the price target for Altria stock, bringing it down to $61 from the previous $65, while still maintaining a Buy rating on the shares. This change was announced by ...

Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

The Food and Drug Administration is facing some backlash ... Vivek Ramaswamy have not been shy about about what they plan to target as their agency guides cut under Trump 2.0. Sen.

And the US Food and Drug Administration (FDA) has banned the use of red dye No. 3 in food, drinks, and ingested drugs. Laguarta said Pepsi doesn't have the dye in its US portfolio. The barrage of ...